The Exhibition Hall: Past, Present and Future
May 21, 2019 | Congress, Exhibits, exhibition
As I sit here at another pharma conference, I start to reflect on how they have changed over the years.
Back in 2004 I joined an agency that produced exhibition stands/booths for pharmaceutical clients. The beginning of the following year was my first taste of how a booth is designed and run; this was an industry I wasn’t familiar with when I joined. The stand we had built was around 400m2 and had three brands running across it. We had absolutely filled this with interactive technology. Each brand had multiple game stations and six 42” plasma screens with rolling content, all of which we had developed in-house, to educate the delegates on how that particular drug worked in a gamified way.
What I hadn’t realised was how much stuff was being used as giveaways. There were small hand-held digital video cameras, laser pointers, bags, pens, Post-it note pads — you name it, we were probably giving it away. All the games had a high score leaderboard, and if you were at the top of it at the end of the day you could collect one of the more lucrative prizes. (Before you get too excited, this was 2005, so the digital cameras had a whopping two megapixels — yes, two megapixels — which was a real game changer back then.)
Over the three days the stand was always packed. At the breaks it was hard to move from your current position. Delegates would strip you of all the pens and bags you were carrying before you had even made it out of the store room. They came in their droves to play the games, get high scores on the leaderboard for a chance to win to the main prize, and collect as much of the giveaways as they could carry or stuff into a tote bag.
Our client wasn’t the only one doing this — their competitors were all doing the same. The hall was filled with pharma companies, big and small, all trying to sell their products to the prospective customer. It was all about who could attract the most delegates with the most attractive interactive technology, and then send them on their way with as much branded merchandise as possible.
One thing I had noticed is the device companies were all pushed to the outside walls with little pop ups exhibiting their products, trying desperately to be noticed.
For the next few years, we as a company started really pushing what was possible with technology. We hacked Wii controllers Xbox cameras and-adapted PlayStation steering wheels to name but a few, all to create bespoke, mind-blowing attracts for our clients.
Fast forward to 2019. The exhibition hall, in my opinion, is a very different place. The reason is compliance.
These big pharma companies are struggling to attract delegates onto their booths. Once the games, the giveaways and the pens, once known as the doctor’s kryptonite, had been removed, there just wasn’t the draw into the hall anymore.
It seems that the only option they have left is to use large LED displays to promote their products. Yes, there are a few stands that are using VR and AR, but again they are restricted. These attracts must be educational and not a game or content that is rewarded with a prize.
A few of the big Pharma companies have decided against attending these shows as there isn’t the return on investment for them that there used to be. Some have decided to invest more money and time in the symposium and then have only a small presence in the exhibition hall.
On the flip side, the device companies have benefitted from this situation. It has allowed them to have the bigger spaces and a greater presence and at some shows, and they can still give away luxury prizes because they don’t have the same restrictions as pharma1.
So my question is, what can these pharma companies do now to entice the delegates back into the hall and onto their booths? Or are we going to see them remove the booth altogether and just run their workshops independently?
1. Association of British HealthTech Industries. Code of Ethical Business Practice, Chapter 9 A48. July 2018. Available at: http://www.abhicodeofpractice.org.uk/multimedia/New%20Folder/ABHI%20Code%20of%20Business%20Practice%20(final)%20-%20July%202018.pdf. Accessed April 2019.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People
Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.
Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...
Age is not just a number when it comes to clinical trials
In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.
Clarity in clinical trials
Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.
Caring for patients’ mental health in clinical trials
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
Driving equitable healthcare: The role of DE&I in clinical trials
Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...
Empowering patients through more accessible clinical trial information
Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...